🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 778.57 +0.6% NASDAQ 100: 751.27 +0.5% Dow Jones: 534.08 -0.5%

Arrowpoint Investment Partners (Singapore) Pte - Q2 2026 13F Filings

AR

Arrowpoint Investment Partners (Singapore) Pte. Ltd.

CIK: 0002032331
Address: Singapore Singapore 9 Straits View 24-08, Marina One West Tower
$459.03 M
Portfolio Value
129
Assets Held
Reporting Period: Q2 2026
Filing Status:
Active
Last Updated: 08/13/2026

Portfolio Summary (Q2 2026)

View Full Portfolio Analysis

Top Buys

Q2 2026
1. C Citigroup
+$32.9 M
2. GS The Goldman Sachs Group
+$31.32 M
3. GPN Global Payments
+$27.87 M
4. NSC Norfolk Southern Corporation
+$25.59 M
5. AEP American Electric Power Company
+$25.44 M

Top Sells

Q2 2026
1. ASX Ase Technology Holding Co
−$3.89 M
2. ASND Ascendis Pharma A/S
−$2.71 M
3. IONS Ionis Pharmaceuticals
−$2.11 M
4. PFE Pfizer
−$2 M
5. REGN Regeneron Pharmaceuticals
−$1.93 M

Asset Allocation

Stocks/ETFs
+405.31%
$339.95 M 74.06%
Options
+172.15%
$119.08 M 25.94%
Debt
$0 0.00%
Other
$0 0.00%

Sector Allocation (Stocks)

Arrowpoint Investment Partners (Singapore) Pte Q2 2026 Filing Summary

Arrowpoint Investment Partners (Singapore) Pte. Ltd. filed its 13F report for Q2 2026 on August 13, 2026. The portfolio totaled 459.03 M reflecting a +307.97% change from the prior quarter, spanning 129 assets. Allocations were 74.1% Equities, 25.9% Options, and 0.0% Debt. The top 10 holdings comprised 63.9% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 82 new positions and 34 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Arrowpoint Investment Partners (Singapore) Pte’s Q2 2026 Filing

Arrowpoint Investment Partners (Singapore) Pte submitted their Form 13F-HR for the Q2 2026 period on 08/13/2026. This was the only submission for the quarter.

In the Q2 2026 filing, Arrowpoint Investment Partners (Singapore) Pte reported a managed portfolio value of 459.03 M, consisting of 129 individual positions.

This page displays the raw filing documents. To see which stocks Arrowpoint Investment Partners (Singapore) Pte bought or sold during Q2 2026, please visit Arrowpoint Investment Partners (Singapore) Pte's Portfolio Analysis page.